Anna B. Alfieri - Concepedia

Author

Anna B. Alfieri

Also Known As

A ALFIERI, A Alfieri, A B Alfieri, A. Alfieri, A. B. Alfieri, A.B Alfieri, A.B. Alfieri, Andrius Osvaldo Alfieri, Anna Alfieri, Anna B Alfieri

Publications

856

Citations

H-Index

Concepts

All Affiliations

Central University of Venezuela Nova Southeastern University IRBM Science Park University of Hertfordshire

About

Anna B. Alfieri is an author at Central University of Venezuela specializing in medicine, pharmacology, and pharmacotherapy.

Top Concepts

#	Concept	H-Index	Publications	Citations
1	Medicine	14	15	633
2	Engineering	2	2	171
3	Health Sciences	2	2	35
4	Natural Sciences	2	2	78
5	Public Health	2	2	103

Anna B. Alfieri

Publications

834

Citations

H-Index

Page 1

	Year	Citations
A novel strategy for reducing phospholipids-based matrix effect in LC–ESI-MS bioanalysis by means of HybridSPE Vincenzo Pucci, Serena Di Palma, Anna B. Alfieri, Journal of Pharmaceutical and Biomedical Analysis Lipid AnalysisLc–esi-ms BioanalysisEngineeringNovel StrategyBiochemistry	2009	150
Effect of lorcaserin on prevention and remission of type 2 diabetes in overweight and obese patients (CAMELLIA-TIMI 61): a randomised, placebo-controlled trial Erin A. Bohula, Benjamin M. Scirica, Silvio E. Inzucchi, The Lancet ObesityMetabolic SyndromeCamellia-timi 61Diabetes ManagementDiabetes	2018	94
Endothelial nitric oxide synthase polymorphism, nitric oxide production, salt sensitivity and cardiovascular risk factors in Hispanics Irene Hoffmann, R Tavares-Mordwinkin, Ana M. Castejón, Journal of Human Hypertension HypertensionVascular DiseaseHuman PolymorphismMetabolic SyndromeNitric Oxide Production	2004	76
Discovery and Synthesis of HIV Integrase Inhibitors: Development of Potent and Orally Bioavailable N-Methyl Pyrimidones Cristina Gardelli, Emanuela Nizi, Ester Muraglia, Journal of Medicinal Chemistry Medicinal ChemistryInteresting CompoundsBiochemistryMedicineDrug Discovery	2007	67
Nitric oxide and salt sensitivity L X Cubeddu, Anna B. Alfieri, Irene Hoffmann, American Journal of Hypertension	2000	55
Identification of MK-5710 ((8aS)-8a-methyl-1,3-dioxo-2-[(1S,2R)-2-phenylcyclo- propyl]-N-(1-phenyl-1H-pyrazol-5-yl)hexahydro-imidazo[1,5-a]pyrazine-7(1H)-carboxamide), a potent smoothened antagonist for use in Hedgehog pathway dependent malignancies, Part 2 Olaf Kinzel, Anna B. Alfieri, Sergio Altamura, Bioorganic & Medicinal Chemistry Letters Medicinal ChemistryPharmaceutical ChemistryPart 2MedicinePathology	2011	37
Nitric oxide synthases and cyclophosphamide-induced cystitis in rats Anna B. Alfieri, Andrés Malavé, Luigi X. Cubeddu Naunyn-Schmiedeberg s Archives of Pharmacology Reactive Nitrogen SpecieMedicineGastroenterologyNitric Oxide SynthasesPharmacology	2001	28
NAD(P)H oxidase p22phox gene C242T polymorphism, nitric oxide production, salt sensitivity and cardiovascular risk factors in Hispanics Ana M. Castejón, J Bracero, I S Hoffmann, Journal of Human Hypertension Metabolic SyndromeSalt SensitivityNitric Oxide ProductionGenetic DeterminantCardiovascular Epidemiology	2006	27
Cyclophosphamide Induced Cystitis: Role of Nitric Oxide Synthase, Cyclooxygenase-1 and 2, and NK <sub>1</sub> Receptors Beatriz E. Linares-Fernández, Anna B. Alfieri The Journal of Urology	2007	27
Differential Long-term Effects of Carvedilol on Proinflammatory and Antiinflammatory Cytokines, Asymmetric Dimethylarginine, and Left Ventricular Function in Patients With Heart Failure Anna B. Alfieri, Luis Briceño, Gabriele Fragasso, Journal of Cardiovascular Pharmacology InflammationThrombosisDifferential Long-term EffectsHeart FailureCardiomyopathy	2008	25

Page 1